Fertility benefits company Progyny shares how it handles startup valuations when looking for deals
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.)
When Progyny went public in 2019, it was one of a handful of healthcare startups braving a largely untested market.
Four years later, Progyny is trading in line with where it started the year and up 93% from its debut. Progyny is a fertility benefits company that works with self-insured employers. It’s a benefit increasingly being offered by employers, and for the full year of 2022 it was a $787 million business for Progyny. The company works with 390 employer clients as of 2023.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
